• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein

tetano

Editor, Senior Moderator
Virology. 2015 Oct 31;487:163-171. doi: 10.1016/j.virol.2015.10.007. [Epub ahead of print]
[h=1]Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein.[/h] Tretyakova I[SUP]1[/SUP], Hidajat R[SUP]1[/SUP], Hamilton G[SUP]1[/SUP], Horn N[SUP]1[/SUP], Nickols B[SUP]1[/SUP], Prather RO[SUP]1[/SUP], Tumpey TM[SUP]2[/SUP], Pushko P[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza VLPs comprised of hemagglutinin (HA), neuraminidase (NA), and matrix (M1) proteins have been previously used for immunological and virological studies. Here we demonstrated that influenza VLPs can be made in Sf9 cells by using the bovine immunodeficiency virus gag (Bgag) protein in place of M1. We showed that Bgag can be used to prepare VLPs for several influenza subtypes including H1N1 and H10N8. Furthermore, by using Bgag, we prepared quadri-subtype VLPs, which co-expressed within the VLP the four HA subtypes derived from avian-origin H5N1, H7N9, H9N2 and H10N8 viruses. VLPs showed hemagglutination and neuraminidase activities and reacted with specific antisera. The content and co-localization of each HA subtype within the quadri-subtype VLP were evaluated. Electron microscopy showed that Bgag-based VLPs resembled influenza virions with the diameter of 150-200nm. This is the first report of quadri-subtype design for influenza VLP and the use of Bgag for influenza VLP preparation.
Copyright ? 2015 Elsevier Inc. All rights reserved.


[h=4]KEYWORDS:[/h] Avian influenza; BIV gag; H10N8; H5N1; H7N9; H9N2; VLP vaccine; Virus-like particle

PMID: 26529299 [PubMed - as supplied by publisher]
 
Back
Top Bottom